Home › Ewing Sarcoma › Oregon › Portland
Ewing Sarcoma clinical trials in Portland, OR
3 studies for Ewing Sarcoma are looking for participants at sites in and around Portland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
RecruitingPhase 1/2
- Oregon Health and Science University ( Site 1004), Portland
Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
RecruitingPhase 2
- Randall Children's Hospital, Portland
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
RecruitingPhase 1
- Oregon Health & Science University, Portland
Ewing Sarcoma trials in other cities
- New York City, NY8 studies
- Houston, TX7 studies
- Memphis, TN7 studies
- Philadelphia, PA7 studies
- Los Angeles, CA6 studies
- Washington, DC6 studies
- Aurora, CO6 studies
- Boston, MA6 studies
- Birmingham, AL5 studies
- Atlanta, GA5 studies
- Cincinnati, OH5 studies
- Nashville, TN4 studies
Other studies in Portland
- Non-Small Cell Lung Cancer49 studies
- Cancer (all types)36 studies
- Breast Cancer33 studies
- Prostate Cancer33 studies
- Metastatic Cancer29 studies
- Ovarian Cancer28 studies
- Colorectal Cancer28 studies
- Lung Cancer27 studies
- Acute Myeloid Leukemia24 studies
- Endometrial Cancer24 studies
- Pancreatic Cancer19 studies
- Head and Neck Squamous Cell Carcinoma19 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.